Colorectal Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Right Hemicolectomy, Left Hemicolectomy, Subtotal Hemicolectomy, Low Anterior Resection, Abdomino-Perineal Resection, Others), By Product (Endoscopes, Electrosurgical Devices, Visual Systems & Handheld Instruments, Sealing & Stapling Devices, Ligation Clips & Dilators, Cutting Instruments (Cutters & Shears), Surgical Accessories), By End-User (Hospitals, Specialty Clinics, Surgery Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 19.45 Billion
CAGR (2026-2031)	7.99%
Fastest Growing Segment	Low Anterior Resection
Largest Market	North America
Market Size (2031)	USD 30.84 Billion

Market Overview

The Global Colorectal Surgery Market will grow from USD 19.45 Billion in 2025 to USD 30.84 Billion by 2031 at a 7.99% CAGR. Colorectal surgery encompasses the specialized medical devices and surgical interventions utilized to diagnose and treat benign or malignant conditions of the colon, rectum, and anus, including colorectal cancer and inflammatory bowel disease. The expansion of this market is primarily driven by the rapidly aging global population and a rising incidence of gastrointestinal disorders that necessitate resection or ostomy procedures. According to the American Cancer Society, in 2025, an estimated 154,270 new cases of colorectal cancer were projected to be diagnosed in the United States. This escalating disease burden creates a sustained demand for surgical instrumentation and directly supports the growth trajectory of the market.

However, the market faces a significant impediment regarding the high capital expenditure required for advanced robotic systems and modern electrosurgical devices. These elevated acquisition and maintenance costs often restrict the adoption of minimally invasive techniques in developing healthcare infrastructures and limit market penetration in cost sensitive regions. Consequently, substantial financial barriers within healthcare institutions can delay the upgrading of surgical suites and impede the broader expansion of premium colorectal care solutions globally.

Key Market Drivers

The increasing global prevalence of colorectal cancer and inflammatory bowel disease serves as the foundational driver for the colorectal surgery market, necessitating a higher volume of resections and therapeutic interventions. As the burden of gastrointestinal malignancies intensifies, healthcare providers are compelled to expand their surgical capabilities to manage the influx of patients requiring complex procedures. According to the World Health Organization, February 2024, in the 'Global Cancer Burden' press release, colorectal cancer ranked as the second leading cause of cancer death worldwide, accounting for approximately 900,000 deaths. This elevated mortality and incidence rate directly correlates with increased procurement of surgical staplers, energy devices, and electrosurgical units, as hospitals strive to improve patient outcomes through timely surgical management.

Simultaneously, the rapid adoption of robotic and minimally invasive surgical techniques is transforming the procedural landscape by offering enhanced precision and reduced recovery times. This shift is fueling the demand for advanced robotic platforms and compatible instrumentation, particularly in developed healthcare systems where value-based care is prioritized. According to Intuitive Surgical, January 2024, in the 'Fourth Quarter and Full Year 2023 Financial Results' press release, worldwide da Vinci procedures grew approximately 22% compared with the prior year, highlighting the accelerating integration of robotic assistance in general surgery. Furthermore, broader screening initiatives are amplifying this surgical demand; according to NHS England, in 2024, the health service delivered a record 3 million urgent cancer referrals, creating a substantial downstream requirement for colorectal surgical resources.

Download Free Sample Report

Key Market Challenges

The significant capital expenditure required for advanced surgical systems serves as a primary restraint on the expansion of the colorectal surgery market. Healthcare institutions, particularly in developing nations and publicly funded systems, often operate with restricted capital equipment budgets. The initial financial outlay for robotic platforms and modern electrosurgical units is prohibitive for many facilities, preventing the transition from traditional open surgery to minimally invasive approaches. This financial barrier directly limits the installed base of equipment, which in turn reduces the recurring volume of proprietary instrument sales that are essential for sustained market revenue.

The operational burden extends beyond the initial purchase, further dissuading hospital administrators from upgrading their surgical capabilities. According to the Royal College of Surgeons of England, in 2024, the capital cost for a robotic surgical system was at least $1.5 million, with recurring annual maintenance costs of $100,000. These elevated costs create a disparity in market penetration, as manufacturers struggle to sell premium technologies in cost-sensitive regions. Consequently, the market experiences slower growth rates as adoption remains concentrated in high-income territories, leaving a large portion of the global demand for colorectal care reliant on older, less expensive methodologies.

Key Market Trends

The migration of select colorectal procedures to Ambulatory Surgery Centers (ASCs) represents a structural shift driven by cost containment and patient-centric care models. Advancements in minimally invasive techniques now enable the safe performance of interventions like complex polypectomies in outpatient settings, incentivized by reimbursement structures favoring lower-cost sites. This transition alleviates inpatient capacity strain while maintaining clinical safety standards for appropriate candidates. According to Cardinal Health, April 2024, in the 'Rapid growth for ambulatory surgery centers' article, the volume of surgical procedures performed in ASCs is projected to expand by at least 25% over the next decade, highlighting the trajectory of this decentralization trend.

The deployment of Artificial Intelligence for surgical decision support is reshaping the sector by moving from mechanical assistance to data-driven intelligent surgery. Manufacturers are integrating machine learning into endoscopic platforms to provide real-time guidance, such as automated polyp detection, which standardizes outcomes and reduces operator variability. This integration addresses clinical needs by enhancing diagnostic accuracy during screening and resection. According to Medtronic, November 2024, in the 'Medtronic awarded VA contract to expand GI Genius AI technology' press release, the U.S. Department of Veterans Affairs finalized an agreement to deploy almost 100 additional AI-powered endoscopy units, underscoring the accelerating institutional adoption of intelligent diagnostic tools.

Segmental Insights

The Low Anterior Resection segment is currently the fastest growing category in the Global Colorectal Surgery Market, largely due to a widespread clinical shift toward sphincter-preserving operations. Surgeons prefer this technique over abdominoperineal resection because it maintains natural bowel function, avoiding permanent stomas and significantly benefiting patient recovery. This trend is supported by the approval of specialized stapling systems by regulatory entities such as the U.S. FDA, which allow for secure connections deep within the pelvis. As a result, hospitals are increasingly adopting this procedure to comply with treatment guidelines that prioritize organ preservation.

Regional Insights

North America holds a commanding share of the Global Colorectal Surgery Market, largely due to the high incidence of colorectal malignancies and chronic bowel disorders. This dominance is supported by the widespread adoption of minimally invasive and robotic surgical systems within a well-funded healthcare ecosystem. Data from the American Cancer Society regarding substantial annual diagnosis rates underscores the urgent need for surgical management in the region. Additionally, the U.S. Food and Drug Administration (FDA) accelerates market expansion through efficient regulatory pathways for new medical devices, reinforcing the region’s status as a hub for surgical innovation.

Recent Developments

• In May 2025, Intuitive Surgical announced that it had obtained clearance from the U.S. Food and Drug Administration (FDA) for its da Vinci Single Port (SP) surgical system to be used in transanal local excision and resection procedures. This regulatory milestone expanded the system's application within the colorectal surgery market, enabling surgeons to perform complex procedures through a natural orifice. The company’s Chief Medical Officer indicated that this new indication would allow for the preservation of more healthy tissue and potentially accelerate patient recovery times by avoiding the need for abdominal incisions in select colorectal cases.
• In August 2024, Colospan Ltd. announced that the U.S. Food and Drug Administration (FDA) had granted Breakthrough Device Designation for its CG-100 Intraluminal Bypass Device. The company developed this single-use device to serve as an alternative to a diverting stoma for patients undergoing colorectal surgery requiring an anastomosis. By creating a temporary protective bypass, the technology aims to reduce the clinical and economic burden associated with stoma creation and reversal. The company’s leadership noted that this designation would expedite the regulatory review process, facilitating faster market access for this novel colorectal surgical solution.
• In May 2024, Ethicon, a subsidiary of Johnson & Johnson MedTech, launched the ECHELON LINEAR Cutter in the United States, targeting improvements in surgical stapling. The company stated that this new device was the first linear cutter to combine proprietary 3D-Stapling Technology with Gripping Surface Technology to enhance staple line integrity. In the context of the colorectal surgery market, the company emphasized that the device was engineered to address critical surgical risks, with data showing a 47% reduction in staple line leaks compared to standard care, thereby potentially improving outcomes for patients undergoing bowel resection.
• In February 2024, Virtual Incision Corporation announced that it had received marketing authorization from the U.S. Food and Drug Administration (FDA) for its MIRA Surgical System. This authorization permitted the company to introduce the device for use in adult colectomy procedures, a common operation in the global colorectal surgery market. The MIRA system was introduced as the world’s first miniaturized robotic-assisted surgery device, designed to offer a compact solution that fits into a standard surgical tray. The company highlighted that this approval marked a significant step in making minimally invasive robotic surgery more accessible without requiring a dedicated operating room infrastructure.

Key Market Players

• Intuitive Surgical
• Medtronic
• Olympus
• Stryker
• Johnson & Johnson
• Karl Storz
• Smith & Nephew
• ConMed
• Boston Scientific
• Richard Wolf

By Type	By Product	By End-User	By Region
Right Hemicolectomy Left Hemicolectomy Subtotal Hemicolectomy Low Anterior Resection Abdomino-Perineal Resection Others	Endoscopes Electrosurgical Devices Visual Systems & Handheld Instruments Sealing & Stapling Devices Ligation Clips & Dilators Cutting Instruments (Cutters & Shears) Surgical Accessories	Hospitals Specialty Clinics Surgery Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Colorectal Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Colorectal Surgery Market, By Type:

• Right Hemicolectomy
• Left Hemicolectomy
• Subtotal Hemicolectomy
• Low Anterior Resection
• Abdomino-Perineal Resection
• Others

• Colorectal Surgery Market, By Product:

• Endoscopes
• Electrosurgical Devices
• Visual Systems & Handheld Instruments
• Sealing & Stapling Devices
• Ligation Clips & Dilators
• Cutting Instruments (Cutters & Shears)
• Surgical Accessories

• Colorectal Surgery Market, By End-User:

• Hospitals
• Specialty Clinics
• Surgery Centers
• Others

• Colorectal Surgery Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE